NVP-BGJ398 ≥99% (by HPLC)

Supplier: Enzo Life Sciences

Synonyms: 3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-[6-[4-(4-ethylpiperazin-1-yl)anilino]pyrimidin-4-yl]-1-methylurea, 3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-(6-((4-(4-ethylpiperazin-1-yl)phenyl)amino)pyrimidin-4-yl)-1-methylurea, Infigratinib

CHM225-0010 CHM225-0025 CHM225-0050 CHM225-0100 CHM225-0200 CHM225-0500 CHM225-1000
76203-224EA 171.13 USD
76203-224 76203-226 76203-228 76203-230 76203-232 76203-234 76203-236
NVP-BGJ398 ≥99% (by HPLC)
NVP-BGJ398

Infigratinib is a pan FGFR kinase inhibitor, and is an orally bioavailable pan inhibitor of human fibroblast growth factor receptors (FGFRs) with potential antiangiogenic and antineoplastic activities.


  • FGFR kinase inhibitor
  • White solid
  • Soluble in DMSO.

Formula: C₂₆H₃₁Cl₂N₇O₃
MW: 560.5 g/mol
Storage Temperature: Freezer
MDL Number: MFCD22123241
CAS Number: 872511-34-7
https://digitalassets.avantorsciences.com/adaptivemedia/rendition?id=a7e61ef27dc6ee9bc01f22cd9c36aa5bdf0b74a4&vid=902bb44aecf8ce9b995b5f0f0eac403afc6d4d58&prid=web&clid=SAPDAM

Order Now

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR